vs
GLOBAL INDUSTRIAL Co（GIC）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是GLOBAL INDUSTRIAL Co的1.8倍（$622.0M vs $345.6M），Royalty Pharma plc净利率更高（34.4% vs 4.2%，领先30.2%），GLOBAL INDUSTRIAL Co同比增速更快（14.3% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 3.4%）
Global Industrial公司总部位于纽约州华盛顿港，核心业务是在北美地区通过品牌电商网站及关系营销渠道，向客户供应工业用品及维护、维修与运营（MRO）用品，主品牌为Global Industrial。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
GIC vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.8倍
$345.6M
营收增速更快
GIC
高出9.5%
4.8%
净利率更高
RPRX
高出30.2%
4.2%
两年增速更快
RPRX
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $345.6M | $622.0M |
| 净利润 | $14.6M | $214.2M |
| 毛利率 | 34.5% | — |
| 营业利润率 | 5.7% | 62.4% |
| 净利率 | 4.2% | 34.4% |
| 营收同比 | 14.3% | 4.8% |
| 净利润同比 | 36.4% | 2.9% |
| 每股收益（稀释后） | $0.37 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GICRPRX
| Q4 25 | $345.6M | $622.0M | ||
| Q3 25 | $353.6M | $609.3M | ||
| Q2 25 | $358.9M | $578.7M | ||
| Q1 25 | $321.0M | $568.2M | ||
| Q4 24 | $302.3M | $593.6M | ||
| Q3 24 | $342.4M | $564.7M | ||
| Q2 24 | $347.8M | $537.3M | ||
| Q1 24 | $323.4M | $568.0M |
净利润GICRPRX
| Q4 25 | $14.6M | $214.2M | ||
| Q3 25 | $18.8M | $288.2M | ||
| Q2 25 | $25.1M | $30.2M | ||
| Q1 25 | $13.6M | $238.3M | ||
| Q4 24 | $10.7M | $208.2M | ||
| Q3 24 | $16.8M | $544.0M | ||
| Q2 24 | $20.3M | $102.0M | ||
| Q1 24 | $13.2M | $4.8M |
毛利率GICRPRX
| Q4 25 | 34.5% | — | ||
| Q3 25 | 35.6% | — | ||
| Q2 25 | 37.1% | — | ||
| Q1 25 | 34.9% | — | ||
| Q4 24 | 33.8% | — | ||
| Q3 24 | 34.0% | — | ||
| Q2 24 | 35.2% | — | ||
| Q1 24 | 34.3% | — |
营业利润率GICRPRX
| Q4 25 | 5.7% | 62.4% | ||
| Q3 25 | 7.4% | 70.1% | ||
| Q2 25 | 9.3% | 36.3% | ||
| Q1 25 | 5.7% | 94.0% | ||
| Q4 24 | 4.8% | 60.9% | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 7.6% | 50.2% | ||
| Q1 24 | 5.4% | -13.0% |
净利率GICRPRX
| Q4 25 | 4.2% | 34.4% | ||
| Q3 25 | 5.3% | 47.3% | ||
| Q2 25 | 7.0% | 5.2% | ||
| Q1 25 | 4.2% | 41.9% | ||
| Q4 24 | 3.5% | 35.1% | ||
| Q3 24 | 4.9% | 96.3% | ||
| Q2 24 | 5.8% | 19.0% | ||
| Q1 24 | 4.1% | 0.8% |
每股收益（稀释后）GICRPRX
| Q4 25 | $0.37 | $0.49 | ||
| Q3 25 | $0.48 | $0.67 | ||
| Q2 25 | $0.65 | $0.07 | ||
| Q1 25 | $0.35 | $0.55 | ||
| Q4 24 | $0.28 | $0.46 | ||
| Q3 24 | $0.44 | $1.21 | ||
| Q2 24 | $0.52 | $0.23 | ||
| Q1 24 | $0.34 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $67.5M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $313.2M | $9.7B |
| 总资产 | $580.8M | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资GICRPRX
| Q4 25 | $67.5M | $618.7M | ||
| Q3 25 | $67.2M | $938.9M | ||
| Q2 25 | $55.1M | $631.9M | ||
| Q1 25 | $39.0M | $1.1B | ||
| Q4 24 | $44.6M | $929.0M | ||
| Q3 24 | $38.9M | $950.1M | ||
| Q2 24 | $38.8M | $1.8B | ||
| Q1 24 | $29.9M | $843.0M |
总债务GICRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益GICRPRX
| Q4 25 | $313.2M | $9.7B | ||
| Q3 25 | $316.0M | $9.6B | ||
| Q2 25 | $305.2M | $9.5B | ||
| Q1 25 | $287.9M | $9.8B | ||
| Q4 24 | $281.1M | $10.3B | ||
| Q3 24 | $279.2M | $10.3B | ||
| Q2 24 | $270.4M | $9.8B | ||
| Q1 24 | $260.2M | $9.9B |
总资产GICRPRX
| Q4 25 | $580.8M | $19.6B | ||
| Q3 25 | $602.5M | $19.3B | ||
| Q2 25 | $586.5M | $18.3B | ||
| Q1 25 | $536.7M | $17.6B | ||
| Q4 24 | $520.7M | $18.2B | ||
| Q3 24 | $531.6M | $18.0B | ||
| Q2 24 | $542.5M | $17.7B | ||
| Q1 24 | $517.4M | $16.1B |
负债/权益比GICRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $19.2M | — |
| 自由现金流率自由现金流/营收 | 5.6% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | 1.37× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $74.7M | — |
8季度趋势，按日历期对齐
经营现金流GICRPRX
| Q4 25 | $20.0M | $827.1M | ||
| Q3 25 | $22.7M | $702.6M | ||
| Q2 25 | $31.7M | $364.0M | ||
| Q1 25 | $3.4M | $596.1M | ||
| Q4 24 | $15.9M | $742.5M | ||
| Q3 24 | $9.6M | $703.6M | ||
| Q2 24 | $18.8M | $658.2M | ||
| Q1 24 | $6.4M | $664.6M |
自由现金流GICRPRX
| Q4 25 | $19.2M | — | ||
| Q3 25 | $22.0M | — | ||
| Q2 25 | $30.3M | — | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $8.7M | — | ||
| Q2 24 | $17.9M | — | ||
| Q1 24 | $5.1M | — |
自由现金流率GICRPRX
| Q4 25 | 5.6% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 1.6% | — |
资本支出强度GICRPRX
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.4% | — |
现金转化率GICRPRX
| Q4 25 | 1.37× | 3.86× | ||
| Q3 25 | 1.21× | 2.44× | ||
| Q2 25 | 1.26× | 12.06× | ||
| Q1 25 | 0.25× | 2.50× | ||
| Q4 24 | 1.49× | 3.57× | ||
| Q3 24 | 0.57× | 1.29× | ||
| Q2 24 | 0.93× | 6.45× | ||
| Q1 24 | 0.48× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GIC
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
